Adenosine Receptor

  • Inhibitory Selectivity
  • Solubility
Catalog No. Product Name Solubility(25°C)
Water DMSO Alcohol
S2790 Istradefylline <1 mg/mL 6 mg/mL <1 mg/mL
S2153 CGS 21680 HCl <1 mg/mL 100 mg/mL <1 mg/mL
S8575 A2AR antagonist 1 <1 mg/mL 61 mg/mL <1 mg/mL
S8105 ZM241385 <1 mg/mL 67 mg/mL <1 mg/mL
S8314 5-Iodotubercidin <1 mg/mL 78 mg/mL <1 mg/mL
S8104 SCH58261 <1 mg/mL 69 mg/mL <1 mg/mL
S7588 Reversine <1 mg/mL 5 mg/mL <1 mg/mL
Catalog No. Information Product Use Citations Product Validations


Istradefylline is a selective adenosine A2A receptor (A2AR) antagonist with Ki of 2.2 nM. Phase 3.


CGS 21680 HCl

CGS 21680 HCl is an adenosine A2 receptor agonist with IC50 of 22 nM, exhibits 140-fold over A1 receptor.


A2AR antagonist 1

A2AR antagonist 1 is a potent A2AR (Adenosine A2A Receptor) antagonist with Ki values of 4 nM and 264 nM for A2AR and A1R, respectively.



ZM-241385 is a high affinity antagonist ligand selective for the adenosine A2A receptor.



5-Iodotubercidin is a potent adenosine kinase inhibitor with IC50 of 26 nM. It inhibits nucleoside transporter, CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2 and PKC.



SCH 58261 is a potent and selective A2a adenosine receptor antagonist with Ki of 2.3 nM and 2 nM for rat A2a and bovine A2a, respectively.



Reversine is a potent human A3 adenosine receptor antagonist with Ki of 0.66 μM, and a pan-aurora A/B/C kinase inhibitor with IC50 of 12 nM/13 nM/20 nM, respectively. Also used for stem cell dedifferentiation.